Subclinical Hypothyroidism as an Independent Determinant of Left Atrial Dysfunction in the General Population.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
25 03 2021
Historique:
received: 05 08 2020
accepted: 08 10 2020
pubmed: 14 10 2020
medline: 21 10 2021
entrez: 13 10 2020
Statut: ppublish

Résumé

Although subclinical hypothyroidism (SCH) is a common clinical entity and carries independent risk for incident heart failure (HF), its possible association with subclinical cardiac dysfunction is unclear. Left ventricular global longitudinal strain (LVGLS) and left atrial (LA) phasic strain can unmask subclinical left heart abnormalities and are excellent predictors for HF. This study aimed to investigate the association between the presence of SCH and subclinical left heart dysfunction in a sample of the general population without overt cardiac disease. We examined 1078 participants who voluntarily underwent extensive cardiovascular health check-ups, including laboratory tests and 2-dimensional speckle-tracking echocardiography to assess LVGLS and LA reservoir, conduit, and pump strain. SCH was defined as an elevated serum thyroid-stimulating hormone level with normal concentration of free thyroxine. Mean age was 62 ± 12 years, and 56% were men. Seventy-eight (7.2%) participants exhibited SCH. Individuals with SCH had significantly reduced LA reservoir (37.1 ± 6.6% vs 39.1 ± 6.6%; P = 0.011) and conduit strain (17.3 ± 6.3% vs 19.3 ± 6.6%; P = 0.012) compared with those with euthyroidism, whereas there was no significant difference in left ventricular ejection fraction, LA volume index, LVGLS, and LA pump strain between the 2 groups. In multivariable analyses, SCH remained associated with impaired LA reservoir strain, independent of age, traditional cardiovascular risk factors, and pertinent laboratory and echocardiographic parameters. including LVGLS (standardized β -0.054; P = 0.032). In an unselected community-based cohort, individuals with SCH had significantly impaired LA phasic function. This association may be involved in the higher incidence of HF in subjects with SCH.

Identifiants

pubmed: 33049040
pii: 5922693
doi: 10.1210/clinem/dgaa730
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1859-e1867

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Koki Nakanishi (K)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Masao Daimon (M)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Department of Clinical Laboratory, The University of Tokyo, Tokyo, Japan.

Yuriko Yoshida (Y)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Naoko Sawada (N)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Kazutoshi Hirose (K)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Kentaro Iwama (K)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Yuko Yamamoto (Y)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Jumpei Ishiwata (J)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Megumi Hirokawa (M)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Hidehiro Kaneko (H)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Tomoko Nakao (T)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Yoshiko Mizuno (Y)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Hiroyuki Morita (H)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Marco R Di Tullio (MR)

Department of Medicine, Columbia University, New York, New York.

Shunichi Homma (S)

Department of Medicine, Columbia University, New York, New York.

Issei Komuro (I)

Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH